Analysis for IBM
- 📈 Growth — 18/30
- 💰 Profitability — 15/20
- 🏦 Financial Health — 12/20
- 💵 Valuation — 14/20
- ⚠️ Risk — 6/10
Overall Score: 55/100
Summary:
📈 Growth & Financial Trajectory
IBM shows an 8-quarter cycle with revenue rising from about $14.46B in 2024 Q1 to about $15.92B in 2026 Q1, a gain of roughly $1.46B (~10%) despite volatility. Net income starts near $1.61B, dips into a small loss in 2024 Q2, then recovers to the $2B+ range in several quarters, but ends around $1.22B in 2026 Q1, signaling durable earnings but modest growth.
💰 Margins & Cash Flow
- Gross margin remains in the mid-to-high 50s percent across quarters, with margins around 53-60% in most periods.
- Operating margin fluctuates, but cash from operations stays robust; quarterly cash from operating activities is generally positive (peaking around $4.3B–$5.2B in late 2024–2026).
- Cash flow from investing is often negative, reflecting capital allocation; financing activity varies seasonally.
🛡️ Balance Sheet & Liquidity
Total assets near $156B; liabilities near $123B; equity around $33B. Current assets about $31.9B vs. current liabilities about $40.1B (current ratio ~ 0.8). Noncurrent liabilities around $83B; balance sheet is asset-heavy but liquidity is modest; ongoing operating cash flow supports resilience.
⚠️ Key Drivers & Risks
- Drivers: Enterprise IT modernization and AI/Data Center demand; cloud/services
- Risks: Cyclical IT spending and valuation sensitivity given leverage; currency exposure